MDPI - Stable Gastric Pentadecapeptide BPC 157 as a Therapy and Safety Key: Discusses cytoprotective healing system, angiogenesis, and NO-system control
Investigations focus on molecular mechanisms and assay readouts only
Predicting cognitive decline using neuropsychiatric symptoms in prodromal Lewy body dementia: A longitudinal study
However, its clinical applicability is severely constrained by poor stability and susceptibility to oxidation, limiting its translational potential
K14 is typically specifically expressed in the proliferative basal layer
Neurological Relevance Preclinical evidence suggests broader neuroprotective potential: In traumatic brain injury models, SS-31 reduced mitochondrial swelling, neuronal loss, and neuroinflammation Aged mice treated with SS-31 showed significantly improved exercise tolerance, muscle strength, and mitochondrial efficiency Studies demonstrate protection against ischemic injury and enhanced cardiac output Phase 3 trials are ongoing for dry age-related macular degeneration and primary mitochondrial myopathy (Stealth BioTherapeutics pipeline) Implications for Brain Aging Mitochondrial dysfunction is a hallmark of brain aging and neurodegeneration